Will Immunotherapy Put Head and Neck Surgeons Out of Business? – Semon Lectures
RM Magazine - autumn 2012 - The Royal Marsden
In our blood | The Royal Marsden
Advance Magazine - Autumn/Winter 2020 by The Royal Marsden - Issuu
6th OF NOVEMBER 12:00-13:00
Royal Marsden researchers named among world's most influential scientists | The Royal Marsden
New treatment destroys head and neck cancer tumours in trial | Cancer | The Guardian
Clinical Research Fellows' Newsletter Summer 2019
Professor Kevin Harrington | The Royal Marsden
Potential of immunotherapy in head and neck cancer | VJOncology
World's first centre for recurrent head and neck cancer launched - Professor Christopher Nutting Oncology
Royal Marsden staff among world's top influential researchers | The Royal Marsden Cancer Charity
Immunotherapy for recurrent or metastatic HNSCC: What are the practical considerations? - touchONCOLOGY
GM herpes virus fights advanced cancers
Professor Kevin Harrington to star in BBC2's Trust me, I'm a Doctor - The Institute of Cancer Research, London
Potential of immunotherapy in head and neck cancer | VJOncology
Game-changing drug doubles head and neck cancer survival | The Royal Marsden
Honorary Trustees - Oracle Cancer Trust
ICR researchers named among world's most influential scientists - The Institute of Cancer Research, London
The ICR on Twitter: "Professor Kevin Harrington explained the basic principles of using viruses to treat cancer and talked about the cancer-killing virus therapy, T-VEC. Find out more about how viral immunotherapies
Potential of immunotherapy in head and neck cancer | VJOncology
Professor Kevin Harrington - The Institute of Cancer Research, London
Professor Kevin Harrington - The Institute of Cancer Research, London
